PMDA drug package insert
フォリルモンP注75
PMDA Prescription drug · 富士製薬工業株式会社 · package insert Sep 16, 2022
Key facts
| Brand names | フォリルモンP注75, フォリルモンP注150 |
|---|---|
| Nonproprietary names | 下垂体性性腺刺激ホルモン |
| Companies | 製造販売元／富士製薬工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 卵胞刺激ホルモン（FSH）製剤 |
| Therapeutic category codes | 872413 |
| YJ codes | 2413403A1040, 2413403D1020 |
| Approval numbers | 21300AMZ00445, 21300AMZ00446 |
| Package insert edition | 第1版 |
| Package insert date | Sep 16, 2022 |
| PMDA document key | 670109_2413403A1040_1 |
| PMDA company code | 670109 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: